![LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC](https://cdn.lincolninternational.com/wp-content/uploads/LGC_Alliance-Pharma_KKR_Ampersand_2022-1.png)
LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC
![Alliance Pharma to acquire LGC's Drug Development Solutions business, with KKR as joint shareholder - Bioanalysis Zone Alliance Pharma to acquire LGC's Drug Development Solutions business, with KKR as joint shareholder - Bioanalysis Zone](https://www.bioanalysis-zone.com/wp-content/uploads/2022/05/editorial-piece-20.png)
Alliance Pharma to acquire LGC's Drug Development Solutions business, with KKR as joint shareholder - Bioanalysis Zone
![U.S. Alliance Pharma Acquires U.K.-based LGC's Drug Development Solutions (DDS) Business | Business Wire U.S. Alliance Pharma Acquires U.K.-based LGC's Drug Development Solutions (DDS) Business | Business Wire](https://mms.businesswire.com/media/20220713005250/en/1511992/23/Alliance_Pharma-Logo.jpg)
U.S. Alliance Pharma Acquires U.K.-based LGC's Drug Development Solutions (DDS) Business | Business Wire
![Chippenham's Alliance Pharma reveals strong growth and further acquisition ambitions - The Business Magazine Chippenham's Alliance Pharma reveals strong growth and further acquisition ambitions - The Business Magazine](https://thebusinessmagazine.co.uk/wp-content/uploads/2022/03/Alliance-Pharma.jpg)